Gland Pharma Limited
GLAND
Ранг среди акций
#3302
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Цена акции
$32.32
Рыночная капитализация
$5.33B
Изменение (1 день)
-3.01%
Изменение (1 год)
47.99%
Страна
IN
Торговля Gland Pharma Limited (GLAND)
Категория
Healthcare
Коэффициент P/B для Gland Pharma Limited (GLAND)
Коэффициент P/B на October 2026 TTM: 4.84
Согласно последним финансовым отчетам и цене акций Gland Pharma Limited, текущий коэффициент P/B (TTM) составляет 4.84. В конце 2024 он составлял 3.43.
История P/B для Gland Pharma Limited с 2017 по 2026
Коэффициент P/B в конце каждого года
| Год | P/B | Изменить |
|---|---|---|
| 2026 (TTM) | 4.84 | 72.92% |
| 2025 | 2.80 | -18.34% |
| 2024 | 3.43 | 30.55% |
| 2023 | 2.62 | -65.05% |
| 2022 | 7.51 | 13.10% |
| 2021 | 6.64 | -14.17% |
| 2020 | 7.73 | -25.51% |
| 2019 | 10.38 | -15.78% |
| 2018 | 12.33 | -8.64% |
| 2017 | 13.49 | 0.00% |
Коэффициент P/B для аналогичных компаний или конкурентов
| Компания | P/B | Разница P/B | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 4.11% |
IN
|
